Skip to main content

Rupee slips 7 paise to 74.53 Against U.S. Dollar

 

The foreign currency trade among banks the rupee began the day on a weak start, trading at 74.79, then dropping further ground and touching 74.53 against the US dollar in early trade, a drop of 7 paise from the previous close. The rupee had closed at 74.46 versus the US dollar on November 15th. The USD-INR spot pair has remained above the 74.30 mark, suggesting a positive level. However, reliance securities in research that trading below 74.12 to 74 levels might drive the pair to the support zone. The midday trading more in Asian trade, boosted by speculation that the Federal Reserve would tighten monetary policy in response to increased inflation.

For further data, traders will be analyzing the US retail sales data and the US industrial output statistics. Crude oil prices rose 0.78% to 82.69$ a, the use. According to exchange data, foreign institutional investors were net purchasers in the capital market, purchasing shares worth 424.74 crores. The 30-share SENSEX was down 124.53 points, or 0.21%, to 60594.18 in domestic equity markets, while the larger NSE Nifty was down 35.45 points, or 0.2%, to 18074.

Labels:

Comments

Post a Comment

Popular posts from this blog

The Asian Paints Price Hike Stroke

This paint business, which was once a stock market favourite, hasn't had a fantastic year. While the Sensex has increased by more than 50%, Asian Paints has only increased by 30%. The Synopsis Asian Paints, the world's largest paint manufacturer, has raised prices by just 3% a year for the past 20 years. That's correct, despite the fact that we've had to cope with out-of-control inflation everywhere, paint costs have never been an issue. The corporation, on the other hand, has finally rolled up its sleeves and is getting down to work. Asian Paints, the industry leader, is raising prices by 7–10 percent starting November 12th. Yes, it's advising everyone to spruce up their homes before Diwali. But, you may wonder, why the abrupt change of heart. Of sure, earnings are important. Sales increased by 32% year over year, from Rs 5,350 crores to almost Rs 7,000 crores, according to the company's latest figures (July-September). However, its net income dropped by 28%, f...
Post a Comment
Read more

Pharm Easy: A Mini Portfolio

  Indian Digital healthcare platform Pharm Easy became the latest startup business in our country and listed in domestic market. Pharm Easy provide health service ranging from tele-communication to radiology test and provide home delivery of medical products.   When we compare the past 3months sales of the company, now the monitary value of sales of the company stood at 30.26 billion Rupees. Pharmacy’s company may consider a private issuance of shares worth up to 12.50 billion rupees. Naspers, a technology-focused investor, as well as organizations connected with global investment group CDPQ and private equity firm TPG, are among the company's investors. The company acquired thyrocare technologies, India's leading diagnostic test provider, in order to diversify its operations. The IPO filing for pharmeasy comes on the same day as Nykaa, an Indian fashion         e-commerce firm, is scheduled to debut on the stock exchange, and Paytm, a finance...
Post a Comment
Read more